SCHEMBL6992143

SCHEMBL6992143

CSc1ccc(C)c2onc(OCCNC(=O)OC(C)(C)C)c12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.42
CA1 P00915 5/20 0.42
CA2 P00918 5/20 0.42
CA9 Q16790 5/20 0.42
HTT P42858 1/20 0.40
IDO1 P14902 3/20 0.39
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PDK2 Q15119 1/20 0.36
SCN9A Q15858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2B6 P20813 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP3A43 Q9HB55 1/20 0.35
GABRA5 P31644 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990613 0.91 CA12 (0.46) CA12CA1CA2CA9HTT
SCHEMBL6990629 0.84 CA12 (0.43) CA12CA1CA2CA9IDO1
SCHEMBL6988079 0.84 CA12 (0.41) CA12CA1CA2CA9IDO1
SCHEMBL6991241 0.83 CA12 (0.40) CA12CA1CA2CA9IDO1
SCHEMBL6993444 0.83 CA12 (0.43) CA12CA1CA2CA9HTT
SCHEMBL6988571 0.81 CA12 (0.43) CA12CA1CA2CA9IDO1
SCHEMBL6992284 0.79 CA12 (0.44) CA12CA1CA2CA9HTT
SCHEMBL6988466 0.77 STK17B (0.40) CA12CA1CA2CA9HTT
SCHEMBL6986596 0.76 IDO1 (0.42) CA12CA1CA2CA9HTT
SCHEMBL8438049 0.76 ALDH1A1 (0.45) CA12CA1CA2CA9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed